Discussion of preferences for life-sustaining care by persons with AIDS. Predictors of failure in patient-physician communication.
OBJECTIVE
To assess the determinants of communication about resuscitation between persons with acquired immunodeficiency syndrome (AIDS) and their physician.


METHODS
Structured patient interview at a staff-model health maintenance organization (HMO), an internal medicine group practice at a private teaching hospital, and an AIDS clinic at a public hospital.


METHODS
289 persons with AIDS.


RESULTS
Only 38% of patients had discussed their preferences for resuscitation with their physician. Using logistic regression, we found that patients were less likely to have discussed resuscitation with their physician if they were nonwhite (odds ratio [OR], 0.49; 95% confidence interval [CI], 0.24 to 0.99), had never been hospitalized (OR, 0.52; 95% CI, 0.27 to 0.99), or were cared for in the HMO (OR, 0.44 relative to the private teaching hospital; 95% CI, 0.23 to 0.82). Patients were more likely to have discussed their preferences if they were not currently taking zidovudine (OR, 1.76; 95% CI, 1.02 to 3.03) and if they had decided to defer life-sustaining therapy (OR, 2.30; 95% CI, 1.35 to 3.91). Among nonwhites, those with a nonwhite physician were more likely to have discussed resuscitation (OR, 4.38; 95% CI, 1.13 to 16.93). Of patients who had not discussed their preferences for life-sustaining care, 72% wanted to do so. Patient desire for discussion of this issue did not vary by race, severity of illness, hospitalization status, use of zidovudine, or site of care.


CONCLUSIONS
A majority of persons with AIDS in this study had not discussed their preferences for life-sustaining care with their physician, despite the desire to do so. Interventions to improve patient-physician communication about resuscitation for nonwhites and other groups at risk of inadequate discussion might lead to clinical decisions that are more consistent with patient preferences.
Section on Health Services and Policy Research, Brigham and Women's Hospital, Boston, MA.
J S
JS
Haas
J S
JS
Weissman
P D
PD
Cleary
J
J
Goldberg
C
C
Gatsonis
G R
GR
Seage
F J
FJ
Fowler
M P
MP
Massagli
H J
HJ
Makadon
A M
AM
Epstein
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy; D000328:Adult; D016223:Advance Directives / Q000523:psychology*; D001900:Boston / Q000453:epidemiology; D003144:Communication Barriers; D005260:Female; D006279:Health Maintenance Organizations; D006779:Hospitals, Public; D006784:Hospitals, Teaching; D006801:Humans; D008020:Life Support Care; D008297:Male; D016017:Odds Ratio; D010358:Patient Participation; D010817:Physician-Patient Relations; D012044:Regression Analysis; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine